RecruitingNot ApplicableNCT06601036

Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

Sponsor

Tanta University

Enrollment

70 participants

Start Date

Sep 17, 2024

Study Type

INTERVENTIONAL

Conditions

Sedation Sevoflurane Awake Fiberoptic Intubation Difficult Airway

Summary

The aim of this study is to compare patient satisfaction and intubating conditions with fiber optic intubation under sevoflurane sedation versus airway blocks in difficult airway patients

Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria4

Age from 18 to 50 years.
Both sexes.
American Society of Anesthesiology (ASA) physical status I-II.
Patients with difficult airway (Mallampati grade 3 and 4 with mouth opening less than 5 cm).

Exclusion Criteria6

Patient refusal.
Patients with bleeding disorders and nasal mass.
Allergy or intolerance to one of the study medications.
Patients with uncontrolled systemic diseases.
patients with gastro-esophageal reflex.
history of nasopharyngeal surgery or drug abuse.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSevoflurane

Patients will undergo fiberoptic intubation under sevoflurane sedation.

DRUG2% Xylocaine (2 ml )

Patients will undergo fiberoptic intubation with bilateral Superior Laryngeal Nerve block and Recurrent laryngeal nerve block.

Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06601036

Related Trials

High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways

NCT073844946 locations

Comparative Study Between Combined Video Laryngoscope and Video Stylet Intubation Versus Combined Video Laryngoscope and Fiberoptic Intubation in a Simulated Difficult Airway

NCT074707361 location